Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Bone Miner Res ; 34(6): 1101-1114, 2019 06.
Article in English | MEDLINE | ID: mdl-30721528

ABSTRACT

Osteoporosis is characterized by low bone mineral density (BMD) and fragility fracture and affects over 200 million people worldwide. Bone quality describes the material properties that contribute to strength independently of BMD, and its quantitative analysis is a major priority in osteoporosis research. Tissue mineralization is a fundamental process requiring calcium and phosphate transporters. Here we identify impaired bone quality and strength in Slc20a2-/- mice lacking the phosphate transporter SLC20A2. Juveniles had abnormal endochondral and intramembranous ossification, decreased mineral accrual, and short stature. Adults exhibited only small reductions in bone mass and mineralization but a profound impairment of bone strength. Bone quality was severely impaired in Slc20a2-/- mice: yield load (-2.3 SD), maximum load (-1.7 SD), and stiffness (-2.7 SD) were all below values predicted from their bone mineral content as determined in a cohort of 320 wild-type controls. These studies identify Slc20a2 as a physiological regulator of tissue mineralization and highlight its critical role in the determination of bone quality and strength. © 2019 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.


Subject(s)
Bone and Bones/physiology , Sodium-Phosphate Cotransporter Proteins, Type III/genetics , Animals , Animals, Newborn , Bone Development , Bone Resorption/physiopathology , Bone and Bones/diagnostic imaging , Calcification, Physiologic , Calcinosis/diagnostic imaging , Calcinosis/genetics , Cells, Cultured , Chondrocytes/metabolism , Humans , Incisor/ultrastructure , Mice, Inbred C57BL , Mice, Knockout , Osteoblasts/metabolism , Phenotype , Skull/diagnostic imaging , Sodium-Phosphate Cotransporter Proteins, Type III/deficiency , Tooth/growth & development , X-Ray Microtomography
2.
J Bone Miner Res ; 34(2): 375-386, 2019 02.
Article in English | MEDLINE | ID: mdl-30395363

ABSTRACT

Polydactyly is a common congenital anomaly of the hand and foot. Postaxial polydactyly (PAP) is characterized by one or more posterior or postaxial digits. In a Pakistani family with autosomal recessive nonsyndromic postaxial polydactyly type A (PAPA), we performed genomewide genotyping, linkage analysis, and exome and Sanger sequencing. Exome sequencing revealed a homozygous nonsense variant (c.478C>T, p.[Arg160*]) in the FAM92A gene within the mapped region on 8q21.13-q24.12 that segregated with the PAPA phenotype. We found that FAM92A is expressed in the developing mouse limb and E11.5 limb bud including the progress zone and the apical ectodermal ridge, where it strongly localizes at the cilia level, suggesting an important role in limb patterning. The identified variant leads to a loss of the FAM92A/Chibby1 complex that is crucial for ciliogenesis and impairs the recruitment and the colocalization of FAM92A with Chibby1 at the base of the cilia. In addition, we show that Fam92a-/- homozygous mice also exhibit an abnormal digit morphology, including metatarsal osteomas and polysyndactyly, in addition to distinct abnormalities on the deltoid tuberosity of their humeri. In conclusion, we present a new nonsyndromic PAPA ciliopathy due to a loss-of-function variant in FAM92A. © 2018 American Society for Bone and Mineral Research.


Subject(s)
Ciliopathies , Codon, Nonsense , Exome , Fingers/abnormalities , Homozygote , Polydactyly , Proteins , Toes/abnormalities , Animals , Carrier Proteins/genetics , Carrier Proteins/metabolism , Ciliopathies/genetics , Ciliopathies/metabolism , Ciliopathies/pathology , Female , Fingers/pathology , Humans , Male , Mice , Mice, Knockout , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Polydactyly/genetics , Polydactyly/metabolism , Polydactyly/pathology , Proteins/genetics , Proteins/metabolism , Toes/pathology , Exome Sequencing
3.
J Pathol ; 239(3): 374-83, 2016 07.
Article in English | MEDLINE | ID: mdl-27126290

ABSTRACT

The epidermis is the outermost layer of skin that acts as a barrier to protect the body from the external environment and to control water and heat loss. This barrier function is established through the multistage differentiation of keratinocytes and the presence of bioactive sphingolipids such as ceramides, the levels of which are tightly regulated by a balance of ceramide synthase and ceramidase activities. Here we reveal the essential role of alkaline ceramidase 1 (Acer1) in the skin. Acer1-deficient (Acer1(-/-) ) mice showed elevated levels of ceramide in the skin, aberrant hair shaft cuticle formation and cyclic alopecia. We demonstrate that Acer1 is specifically expressed in differentiated interfollicular epidermis, infundibulum and sebaceous glands and consequently Acer1(-/-) mice have significant alterations in infundibulum and sebaceous gland architecture. Acer1(-/-) skin also shows perturbed hair follicle stem cell compartments. These alterations result in Acer1(-/-) mice showing increased transepidermal water loss and a hypermetabolism phenotype with associated reduction of fat content with age. We conclude that Acer1 is indispensable for mammalian skin homeostasis and whole-body energy homeostasis. © 2016 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.


Subject(s)
Alkaline Ceramidase/metabolism , Alopecia/enzymology , Ceramides/metabolism , Energy Metabolism , Homeostasis , Alkaline Ceramidase/genetics , Alopecia/physiopathology , Animals , Cell Differentiation , Epidermis/abnormalities , Epidermis/enzymology , Female , Hair Follicle/abnormalities , Hair Follicle/enzymology , Humans , Keratinocytes/enzymology , Keratinocytes/physiology , Male , Mice , Mice, Inbred C57BL , Pituitary Gland/abnormalities , Pituitary Gland/enzymology , Sebaceous Glands/abnormalities , Sebaceous Glands/enzymology , Skin/enzymology , Skin Abnormalities , Sphingolipids/metabolism
4.
Am J Pathol ; 181(5): 1518-23, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22940073

ABSTRACT

Protein tyrosine phosphatase receptor type Z (Ptprz) is widely expressed in the mammalian central nervous system and has been suggested to regulate oligodendrocyte survival and differentiation. We investigated the role of Ptprz in oligodendrocyte remyelination after acute, toxin-induced demyelination in Ptprz null mice. We found neither obvious impairment in the recruitment of oligodendrocyte precursor cells, astrocytes, or reactive microglia/macrophage to lesions nor a failure for oligodendrocyte precursor cells to differentiate and remyelinate axons at the lesions. However, we observed an unexpected increase in the number of dystrophic axons by 3 days after demyelination, followed by prominent Wallerian degeneration by 21 days in the Ptprz-deficient mice. Moreover, quantitative gait analysis revealed a deficit of locomotor behavior in the mutant mice, suggesting increased vulnerability to axonal injury. We propose that Ptprz is necessary to maintain central nervous system axonal integrity in a demyelinating environment and may be an important target of axonal protection in inflammatory demyelinating diseases, such as multiple sclerosis and periventricular leukomalacia.


Subject(s)
Axons/enzymology , Axons/pathology , Central Nervous System/enzymology , Central Nervous System/pathology , Demyelinating Diseases/enzymology , Demyelinating Diseases/pathology , Animals , Apoptosis , Axons/ultrastructure , Cell Differentiation , Central Nervous System/ultrastructure , Mice , Oligodendroglia/enzymology , Oligodendroglia/pathology , Receptor-Like Protein Tyrosine Phosphatases, Class 5/deficiency , Receptor-Like Protein Tyrosine Phosphatases, Class 5/metabolism , Spinal Cord/enzymology , Spinal Cord/pathology , Spinal Cord/ultrastructure , Stem Cells/enzymology , Stem Cells/pathology
5.
J Inflamm (Lond) ; 7: 16, 2010 Mar 30.
Article in English | MEDLINE | ID: mdl-20353590

ABSTRACT

BACKGROUND: PTPH1 is a protein tyrosine phosphatase expressed in T cells but its effect on immune response is still controversial. PTPH1 dephosphorylates TCRzeta in vitro, inhibiting the downstream inflammatory signaling pathway, however no immunological phenotype has been detected in primary T cells derived from PTPH1-KO mice. The aim of the present study is to characterize PTPH1 phenotype in two in vivo inflammatory models and to give insights in possible PTPH1 functions in cytokine release. METHODS: We challenged PTPH1-KO mice with two potent immunomodulatory molecules, carrageenan and LPS, in order to determine PTPH1 possible role in inflammatory response in vivo. Cytokine release, inflammatory pain and gene expression were investigated in challenged PTPH1-WT and KO mice. RESULTS: The present study shows that carrageenan induces a trend of slightly increased spontaneous pain sensitivity in PTPH1-KO mice compared to WT (wild-type) littermates, but no differences in cytokine release, induced pain perception and cellular infiltration have been detected between the two genotypes in this mouse model. On the other hand, LPS-induced TNFalpha, MCP-1 and IL10 release was significantly reduced in PTPH1-KO plasma compared to WTs 30 and 60 minutes post challenge. No cytokine release modulation was detectable 180 minutes post LPS challenge. CONCLUSION: In conclusion, the present study points out a slight potential role for PTPH1 in spontaneous pain sensitivity and it indicates that this phosphatase might play a role in the positive regulation of the LPS-induced cytokines release in vivo, in contrast to previous reports indicating PTPH1 as potential negative regulator of immune response.

6.
Behav Brain Res ; 201(1): 29-40, 2009 Jul 19.
Article in English | MEDLINE | ID: mdl-19428613

ABSTRACT

Receptor like protein tyrosine phosphatase zeta (RPTPz) (also known as RPTPbeta or PTPxi) is a tyrosine phosphatase widely expressed in the nervous system, thought to play a role in cell-cell communication. However, knocking out RPTPz does not induce major neural abnormalities in mice. In order to better assess the potential role of RPTPz in various neural functions, we performed a comprehensive behavioural characterization of CNS/PNS functions in knockout mice (RPTPz -/-) confirming previously observed impaired working memory functions and further demonstrating an altered motor coordination. Moreover, RPTPz -/- mice displayed reduced responses to moderate thermal and tactile stimuli, both in baseline and under inflammatory conditions. These findings assign novel functional role of RPTPz in motor coordination and nociception.


Subject(s)
Brain/physiology , Memory/physiology , Motor Activity/physiology , Pain/metabolism , Receptor-Like Protein Tyrosine Phosphatases, Class 5/metabolism , Reflex, Startle/physiology , Animals , Body Composition/physiology , Body Weight/physiology , Brain/drug effects , Drinking Behavior/physiology , Evoked Potentials, Motor , Feeding Behavior/physiology , Male , Maze Learning/physiology , Mice , Mice, Knockout , Muscle, Skeletal/physiology , Neural Conduction/physiology , Pain/chemically induced , Physical Stimulation , Receptor-Like Protein Tyrosine Phosphatases, Class 5/genetics , Seizures/chemically induced , Sensory Thresholds/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...